Search results for "Antivirals"


 
Results 91 - 100 of about 103 for "Antivirals".
Sort by: Relevance | Newest | Oldest

Panel issues updated guidance on ART for HIV treatment, prevention

The recommendations from the International Antiviral Society-USA cover initiation of antiretroviral therapy (ART), switching regimens, ART in older patients with HIV, and HIV and COVID-19, among other topics.
https://immattersacp.org/weekly/archives/2022/12/06/1.htm
6 Dec 2022

MKSAP Quiz: Lower extremity edema, rash

A 31-year-old woman is evaluated for lower extremity edema, a rash over both legs, and fatigue that have worsened during the past 3 months. She has no other medical problems and takes no medications. Following a physical exam and lab studies, what viral study will support the most likely diagnosis?
https://immattersacp.org/archives/2023/02/mksap-quiz-lower-extremity-edema-rash.htm
1 Feb 2023

COVID-19 rebound occurs with or without antivirals, doesn't affect outcomes, studies find

Rebound of both COVID-19 symptoms and viral load was rare in untreated, unvaccinated outpatients, one study showed, while another found similar rates of viral rebound in patients treated with nirmatrelvir-ritonavir, molnupiravir, or neither antiviral.
https://immattersacp.org/weekly/archives/2023/02/21/2.htm
21 Feb 2023

PASC defined, analyzed by latest COVID-19 studies

Two recent studies focused on postacute sequelae of SARS-CoV-2 (PASC), while another assessed the effectiveness of nirmatrelvir-ritonavir and molnupiravir in reducing morbidity and mortality from COVID-19.
https://immattersacp.org/weekly/archives/2023/06/06/2.htm
6 Jun 2023

ID, liver societies update guidance for HCV testing, management

Major changes to guidance on hepatitis C virus (HCV) include an emphasis on universal screening, new recommendations for managing incomplete treatment adherence, and expansion of treatment eligibility, among others.
https://immattersacp.org/weekly/archives/2023/06/06/1.htm
6 Jun 2023

Latest COVID-19 studies show need for repeat rapid testing, targeting of antiviral prescriptions

Viral load of SARS-CoV-2 doesn't peak until the fourth day of symptoms, one study found, while other research only saw an effect of nirmatrelvir/ritonavir on death and hospitalization among those who were moderately or severely immunocompromised, not in other high-risk groups.
https://immattersacp.org/weekly/archives/2023/10/03/2.htm
3 Oct 2023

New findings on antiviral flu treatment

A recent study raises doubts about whether oseltamivir should be promoted as a way to prevent hospitalization in low-risk patients.
https://immattersacp.org/archives/2023/11/new-findings-on-antiviral-flu-treatment.htm
1 Nov 2023

PrEPare for HIV care

Internal medicine physicians are already trained to care for complex medical conditions, and HIV is no different, especially as adults age and develop diabetes, heart disease, and other conditions.
https://immattersacp.org/archives/2023/11/prepare-for-hiv-care.htm
1 Nov 2023

MKSAP Quiz: Evaluation for multiple myeloma

A 64-year-old man is evaluated following a recent diagnosis of multiple myeloma. Chemotherapy is planned to begin in 14 days. Which prophylactic therapy is indicated today?
https://immattersacp.org/weekly/archives/2023/12/05/3.htm
5 Dec 2023

CDC publishes guidance on testing for flu, COVID-19

Patients presenting with acute respiratory illness should be tested for SARS-CoV-2 with nucleic acid detection or antigen detection assay, as well as flu if the results will change clinical management or infection control decisions, the CDC said.
https://immattersacp.org/weekly/archives/2023/12/19/1.htm
19 Dec 2023

Result Page: Prev   5   6   7   8   9   10   11   Next